A 15-year-old boy, with a history of psychomotor retardation which began at the age of two years (with a retardation of walk which had started at the age of 20 months) and continued steady until the age of 13 years, presented in 2012 with focal epilepsy, further walk troubles and headaches.
Observation
A 15-year-old boy, with a history of psychomotor retardation which began at the age of two years (with a retardation of walk which had started at the age of 20 months) and continued steady until the age of 13 years, presented in 2012 with focal epilepsy, further walk troubles and headaches.
The child's symptoms had previously been followed by a neurologist, who prescribed a medical treatment, unreported by the family. In June 2015, he developed an ataxia and recurrence of focal epilepsy.
The lumbar puncture revealed an elevated lactate ratio. MRI and MRspectroscopy imaging were undertaken, seeking a metabolic neuropathology.
Results
The MRI revealed a wide signal abnormality, type of T2, FLAIR and diffusion hyperintensity involving the cortical and white matters of the right fronto-parietal regions and the occipital lobes (Figures 1 and 2 ).
ADC cartography, showed a heterogeneous map, with regions of elevated ADC and some others with lowered ADC; these latter areas correspond with cytotoxic edema (Figure 2 ).
Proton-MR-Spectroscopy showed an elevated lactate ratio in both normal and pathological regions and in cerebrospinal fluid (CSF) with decreased N-acetylaspartate (NAA) ratio in pathological regions (Figure 3 ).
In retrospective review with the results of a previous lumbar puncture (elevated lactate ratio), a metabolic pathology was suspected, and more precisely mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like syndrome (MELAS), which can be associated with these typical imaging features.
Discussion
MELAS syndrome is one of the most frequent maternally inherited mitochondrial disorders. It affects selectively the nervous system and muscles [1] . Diagnostic criteria of MELAS syndrome were published in 1992, and include the following criteria: 1). Stroke-like episodes occurring before the age of 40, with a mean age onset at 15 years old.
2). Encephalopathy with seizures and/or dementia. Open Access
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Stroke like lesions (SLL) are multifocal signal abnormalities in the cortical grey matter that do not match with vascular territory, but whose signal evolution looks like stroke.
In the acute phase, MRI shows high signal intensity in T2 and FLAIR weighted imaging of both grey and white matters, and hypo signal intensity on T1WI.
DWI and ADC sequences may show restricted diffusion in the SLL areas with a variable ADC. In fact, early reports showed an elevated ADC in stroke-like lesions due to a vasogenic edema, however recent reports showed that a cytotoxic edema can occur during acute phase of stroke-like episode, and may show a decreased ADC or mixed areas of high and low ADC. This is mainly due to different levels of mitochondrial impairment [24] .
Spectroscopy findings are not specific to MELAS. It can show a decrease in N-acetylaspartate (NAA) that reflects a loss or impairment of neurons and an increase in lactate that reflects anaerobic metabolism. In addition, the lactate peak may be found in normal-appearing areas on MRI, suggesting and supporting the mitochondrial cytopathy theory [1, 4] .
In the sub acute phase, MRI findings are compatible with cortical laminar necrosis.
Cortical atrophy and symmetric basal ganglia and thalamic calcifications are also common imaging findings during the evolution of the disease. 
Conclusion
The rarity of MELAS syndrome and the complexity of its clinical features render it difficult to diagnose. A radiologist has to think MELAS in a patient with acute "stroke-like" cortical lesions that cross usual vascular territories and fluctuate through time. DWI and spectroscopy (in both pathologic and uninvolved brain and in CSF) are helpful tools providing information to obtain an accurate diagnosis. Diffusion B1000 and ADC cartography shows heterogeneous map with regions of increased ADC (green arrow) and regions with restricted diffusion (red arrow). These latter correspond with ischemic regions.
